In: Accounting
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:
| 
 1  | 
 Dec. 31, 20Y3  | 
 Dec. 31, 20Y2  | 
|
| 
 2  | 
 Assets  | 
||
| 
 3  | 
 Cash  | 
 $626,170.00  | 
 $585,760.00  | 
| 
 4  | 
 Accounts receivable (net)  | 
 227,840.00  | 
 208,880.00  | 
| 
 5  | 
 Inventories  | 
 641,390.00  | 
 616,790.00  | 
| 
 6  | 
 Investments  | 
 0.00  | 
 240,820.00  | 
| 
 7  | 
 Land  | 
 327,380.00  | 
 0.00  | 
| 
 8  | 
 Equipment  | 
 704,290.00  | 
 554,020.00  | 
| 
 9  | 
 Accumulated depreciation-equipment  | 
 (167,160.00)  | 
 (148,930.00)  | 
| 
 10  | 
 Total assets  | 
 $2,359,910.00  | 
 $2,057,340.00  | 
| 
 11  | 
 Liabilities and Stockholders’ Equity  | 
||
| 
 12  | 
 Accounts payable (merchandise creditors)  | 
 $424,670.00  | 
 $404,080.00  | 
| 
 13  | 
 Accrued expenses payable (operating expenses)  | 
 43,080.00  | 
 52,050.00  | 
| 
 14  | 
 Dividends payable  | 
 24,920.00  | 
 19,300.00  | 
| 
 15  | 
 Common stock, $2 par  | 
 150,000.00  | 
 100,000.00  | 
| 
 16  | 
 Paid-in capital: Excess of issue price over par—common stock  | 
 417,500.00  | 
 280,000.00  | 
| 
 17  | 
 Retained earnings  | 
 1,299,740.00  | 
 1,201,910.00  | 
| 
 18  | 
 Total liabilities and stockholders’ equity  | 
 $2,359,910.00  | 
 $2,057,340.00  | 
The income statement for the year ended December 31, 20Y3, is as follows:
| 
 1  | 
 Sales  | 
 $5,367,766.00  | 
|
| 
 2  | 
 Cost of goods sold  | 
 3,306,180.00  | 
|
| 
 3  | 
 Gross profit  | 
 $2,061,586.00  | 
|
| 
 4  | 
 Operating expenses:  | 
||
| 
 5  | 
 Depreciation expense  | 
 $18,230.00  | 
|
| 
 6  | 
 Other operating expenses  | 
 1,755,888.00  | 
|
| 
 7  | 
 Total operating expenses  | 
 1,774,118.00  | 
|
| 
 8  | 
 Operating income  | 
 $287,468.00  | 
|
| 
 9  | 
 Other income:  | 
||
| 
 10  | 
 Gain on sale of investments  | 
 39,070.00  | 
|
| 
 11  | 
 Income before income tax  | 
 $326,538.00  | 
|
| 
 12  | 
 Income tax expense  | 
 133,028.00  | 
|
| 
 13  | 
 Net income  | 
 $193,510.00  | 
Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:
| a. The investments were sold for $279,890 cash. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| b. Equipment and land were acquired for cash. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| c. There were no disposals of equipment during the year. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| d. The common stock was issued for cash. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 
 e. There was a $95,680 debit to Retained Earnings for cash dividends declared. 
 
  |